Open Access 09.06.2020 | COVID-19 | Letter
Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial
Erschienen in: Trials | Ausgabe 1/2020